Patents by Inventor Adam Heller

Adam Heller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10368133
    Abstract: A system includes a memory and at least one processor to transmit information associated with a plurality of talents to a client computing device, receive a selection of at least one talent of the plurality of talents from the client computing device associated with a user profile, determine a list of shows featuring the at least one talent, each show in the list of shows having a rating greater than or equal to a particular threshold, transmit the list of shows featuring the at least one talent to the client computing device, receive feedback for each show of the list of shows from the client computing device, and transmit a list of recommended shows available from subscribed media providers to the client computing device based on the feedback.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: July 30, 2019
    Inventors: William Edward Denk, Jr., Nima Jalali, James Heller, Adam William Denk
  • Publication number: 20190209059
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: March 18, 2019
    Publication date: July 11, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: 10328044
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: June 25, 2019
    Assignee: SynAgile Corporation
    Inventor: Adam Heller
  • Publication number: 20190167165
    Abstract: In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 6, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Adam Heller, Benjamin Jay Feldman, Shridhara Alva Karinka, Yi Wang, John R. Galasso
  • Patent number: 10300033
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: May 28, 2019
    Assignee: SynAgile Corporation
    Inventor: Adam Heller
  • Publication number: 20190117605
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Application
    Filed: December 14, 2018
    Publication date: April 25, 2019
    Inventors: Adam HELLER, Ephraim HELLER, Karl Göran WESTERBERG, John SPIRIDIGLIOZZI
  • Patent number: 10231654
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: March 19, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Thomas A. Peyser, Adam Heller
  • Publication number: 20190069823
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Application
    Filed: November 5, 2018
    Publication date: March 7, 2019
    Applicant: Abbott Diabetes Care Inc
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Patent number: 10219730
    Abstract: Novel transition metal complexes of iron, cobalt, ruthenium, osmium, and vanadium are described. The transition metal complexes can be used as redox mediators in enzyme based electrochemical sensors. In such instances, transition metal complexes accept electrons from, or transfer electrons to, enzymes at a high rate and also exchange electrons rapidly with the sensor. The transition metal complexes include at least one substituted or unsubstituted biimidazole ligand and may further include a second substituted or unsubstituted biimidazole ligand or a substituted or unsubstituted bipyridine or pyridylimidazole ligand. Transition metal complexes attached to polymeric backbones are also described.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: March 5, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Fei Mao, Adam Heller
  • Patent number: 10201301
    Abstract: In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: February 12, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Adam Heller, Benjamin Jay Feldman, Shridhara Alva Karinka, Yi Wang, John R. Galasso
  • Patent number: 10117606
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: November 6, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Publication number: 20180192932
    Abstract: Analyte sensor assemblies comprising: an electrochemical sensor for determining a concentration of an analyte and an electrochemical sensor control unit. The electrochemical sensor comprising a working electrode having a sensing layer and a non-crosslinked cubic phase lyotropic liquid crystal membrane disposed over the sensing layer, the sensing layer comprising an analyte-responsive enzyme, and a counter electrode in communication with the working electrode. And the electrochemical sensor control unit comprising a housing adapted for placement on or implantation in a patient's skin, and sensor control unit electronics. Wherein a measured current from an applied potential between the working electrode and the counter electrode correlates to a concentration of an analyte.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 12, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Adam Heller, Pawel Rowinski, Benjamin J. Feldman
  • Publication number: 20180177752
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Application
    Filed: February 2, 2018
    Publication date: June 28, 2018
    Inventors: Adam HELLER, Ephraim HELLER, Karl Göran WESTERBERG, John SPIRIDIGLIOZZI
  • Patent number: 10004439
    Abstract: Ceria nanoparticle compositions for use as electrode materials for in vivo electrochemical analyte sensors (e.g., glucose sensors) are provided, for example to form a cathode or a reference electrode. The ceria nanoparticle compositions may be combined with a conductive material (e.g., mixed with) to form the cathode or the reference electrode, or the ceria nanoparticle compositions may be deposited over conductive material to form the cathode or the reference electrode. Electrochemical in vivo sensors for monitoring the concentration of an analyte having a reference electrode and/or a cathode that includes a ceria nanoparticle composition, and methods for monitoring an analyte concentration using the electrochemical sensors are also described. Methods of making in vivo electrochemical analyte sensors having a reference electrode and/or a cathode that includes a ceria nanoparticle composition are also provided.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: June 26, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Adam Heller
  • Patent number: 10006880
    Abstract: Ceria nanoparticle compositions for use with in vitro electrochemical chemical or biochemical sensors (e.g., test strip glucose sensors), for example to form a cathode or a reference electrode, are provided. The ceria nanoparticle compositions may be combined with a conductive material (e.g., mixed with) to form the cathode or the reference electrode or the ceria nanoparticle compositions may be deposited over a layer of conductive material to form the cathode or the reference electrode. Electrochemical in vitro sensors for determining the concentration of an analyte having a reference electrode and/or a cathode including a ceria nanoparticle composition, and methods for determining an analyte concentration using the electrochemical sensors are also described. Methods of making in vitro electrochemical sensors having a reference electrode and/or a cathode including a ceria nanoparticle composition are also provided.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: June 26, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Adam Heller
  • Publication number: 20180128767
    Abstract: A sensor utilizing a non-leachable or diffusible redox mediator is described. The sensor includes a sample chamber to hold a sample in electrolytic contact with a working electrode, and in at least some instances, the sensor also contains a non-leachable or a diffusible second electron transfer agent. The sensor and/or the methods used produce a sensor signal in response to the analyte that can be distinguished from a background signal caused by the mediator. The invention can be used to determine the concentration of a biomolecule, such as glucose or lactate, in a biological fluid, such as blood or serum, using techniques such as coulometry, amperometry, and potentiometry. An enzyme capable of catalyzing the electrooxidation or electroreduction of the biomolecule is typically provided as a second electron transfer agent.
    Type: Application
    Filed: January 3, 2018
    Publication date: May 10, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benajmin J. Feldman, Adam Heller, Ephraim Heller, Fei Mao, Joseph A. Vivolo, Jeffery V. Funderburk, Fredric C. Colman, Rajesh Krishnan
  • Patent number: 9931462
    Abstract: The present disclosure relates, according to some embodiments, to methods, devices, and systems for fluid delivery to a subject using pumps, for example, non-gassing, direct current (DC), electro-osmotic pumps. In some embodiments, delivery of an aqueous fluid may be achieved by contacting the aqueous liquid with an electro-osmotic pump comprising (i) a cathode (e.g., a cathode comprising porous carbon coated with a cerium oxide-comprising coating), (ii) an anode (e.g., an anode comprising porous carbon coated with a cerium oxide-comprising coating), and (iii) a ceramic membrane (e.g., a ceramic membrane formed by fusing uncoated silica spheres, phosphosilicic-acid-coated fused silica spheres, or borosilicic-acid-coated fused silica spheres, wherein the fused spheres are randomly packed between the cathode and the anode) and/or optionally applying (a) a constant potential difference or constant voltage between the anode and the cathode of from about 0.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: April 3, 2018
    Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Adam Heller, Rajaram K. Nagarale
  • Patent number: 9907500
    Abstract: The present invention is directed to membranes composed liquid crystals having continuous aqueous channels, such as a lyotropic liquid crystal, including a cubic phase lyotropic liquid crystal, and to electrochemical sensors equipped with such membranes. The membranes are useful in limiting the diffusion of an analyte to a working electrode in an electrochemical sensor so that the sensor does not saturate and/or remains linearly responsive over a large range of analyte concentrations. Electrochemical sensors equipped with membranes of the present invention demonstrate considerable sensitivity and stability, and a large signal-to-noise ratio, in a variety of conditions.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: March 6, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Adam Heller, Pawel Rowinski, Benjamin J. Feldman
  • Patent number: 9901561
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: February 27, 2018
    Assignee: SynAgile Corporation
    Inventors: Adam Heller, Ephraim Heller, Karl Göran Westerberg, John Spiridigliozzi
  • Patent number: 9891185
    Abstract: A sensor utilizing a non-leachable or diffusible redox mediator is described. The sensor includes a sample chamber to hold a sample in electrolytic contact with a working electrode, and in at least some instances, the sensor also contains a non-leachable or a diffusible second electron transfer agent. The sensor and/or the methods used produce a sensor signal in response to the analyte that can be distinguished from a background signal caused by the mediator. The invention can be used to determine the concentration of a biomolecule, such as glucose or lactate, in a biological fluid, such as blood or serum, using techniques such as coulometry, amperometry, and potentiometry. An enzyme capable of catalyzing the electrooxidation or electroreduction of the biomolecule is typically provided as a second electron transfer agent.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: February 13, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Adam Heller, Ephraim Heller, Fei Mao, Joseph A. Vivolo, Jeffery V. Funderburk, Fredric C. Colman, Rajesh Krishnan